Progression of head and neck squamous cell cancer

被引:0
|
作者
József Tímár
Orsolya Csuka
Éva Remenár
Gábor Répássy
Miklós Kásler
机构
[1] National Institute of Oncology,Department of Oto
[2] Semmelweis University,Rhyno
来源
关键词
head and neck cancer; invasion marker; lymphatic metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Squamous cell cancer in the head and neck region (HNSC) is unique concerning its progression since it remains locoregional for long time and visceral metastases develop only in a later stage of the disease. Accordingly, molecular markers of the local invasion and the lymphatic dissemination both have critical importance. HNSC progression is associated with deregulated control of cell proliferation and apoptosis but it seems equally significant the disregulation of the proteolytic machineries. Here we outline the lymphatic metastatic cascade for HNSC to depict key molecular determinants as possible prognostic factors or therapeutic targets identifying immunological selection as a major feature. Unlike in local spreading, invasive potential of cancer cells seems to be less significant during lymphatic dissemination due to the anatomical properties of the lymphatic vessels and tissues. There is a general believe that HNSC is one disease however, data indicate that the anatomical localization of the tumor (the “soil”) such as oral, lingual, glottic or pharyngeal has a significant effect on the gene expression profile and corresponding biological behavior of HNSC. Furthermore, even the endocrine milieu of the host was proved to be influential in modulating the progression of HNSC. Gene expression profiling techniques combined with proteomics could help to define and select usefull genetic and biomarkers of progression of HNSC, some of them could well be potential novel therapeutic target.
引用
收藏
页码:107 / 127
页数:20
相关论文
共 50 条
  • [41] The role of docetaxel in the management of squamous cell cancer of the head and neck
    Glisson, BS
    ONCOLOGY-NEW YORK, 2002, 16 (06): : 83 - 87
  • [42] Induction chemotherapy in the management of squamous cell cancer of the head and neck
    Posner, MR
    Colevas, AD
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 (02): : 73 - 75
  • [43] Human Papilloma Virus in Head and Neck Squamous Cell Cancer
    Kermani, I. Asvadi
    Seifi, S.
    Dolatkhah, R.
    Kermani, A. Asvadi
    Sakhinia, E.
    Ebrahimi, A.
    Lotfi, A.
    Hajalipour, S.
    Dastgiri, S.
    Esmaieli, H. A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S550 - S551
  • [44] Update on role of chemotherapy in head and neck squamous cell cancer
    Marur S.
    Forastiere A.A.
    Indian Journal of Surgical Oncology, 2010, 1 (2) : 85 - 95
  • [45] Tumor markers and biomarkers in squamous cell cancer of the head and neck
    Lordick, F.
    Krauss, J.
    Jaeger, D.
    HNO, 2008, 56 (09) : 881 - 885
  • [46] Chemoradiotherapy in unresectable squamous cell head and neck cancer - In reply
    Adelstein, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) : 3887 - 3888
  • [47] Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
    Kumar, Harish A.
    Desai, Anupama
    Mohiddin, Gouse
    Mishra, Pallavi
    Bhattacharyya, Arnab
    Nishat, Roquaiya
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2023, 15 : S826 - S830
  • [48] Cancer stem cells in head and neck squamous cell carcinoma
    Christina Karamboulas
    Keira Pereira
    Elzbieta Hyatt
    Laurie E Ailles
    BMC Proceedings, 7 (Suppl 2)
  • [49] Nivolumab for Squamous-Cell Cancer of Head and Neck REPLY
    Ferris, Robert
    Gillison, Maura L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (06): : 596 - 596
  • [50] Importance of Hpv Positivity in Squamous Cell Head and Neck Cancer
    Jeremic, Branislav
    Ozyigit, Gokhan
    Dubinsky, Pavol
    Filipovic, Nenad
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (03): : 204 - 214